Author

Matthew J Johnson

University of Minnesota

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Bioengineering· 1 Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1 Approach:mechanistic / dynamical model· 1 Organism:mouse· 1 Organism:rat· 1

Frequent Co-Authors

Branden S. MoriarityiD· 2 shared Beau R. WebberiD· 1 shared David J. OddeiD· 1 shared Dawn M. DudleyiD· 1 shared Emil LouiD· 1 shared Jae‐Woong Chang· 1 shared Jasmine FooiD· 1 shared Joshua B. KruegeriD· 1 shared

Activity by Year

2026-2026 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 27 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersBioengineering

Branden S. MoriarityORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Multiplex engineering of rhesus macaque NK cells enhances homing to sites of HIV replication in B cell follicles.

Liliana Kopeck Thron, Mary S. Pampusch, Jae‐Woong Chang, Joshua B. Krueger, Maxwell E. Cantor, Matthew J Johnson, Dawn M. Dudley, Branden S. Moriarity, Pamela J. Skinner

This study develops and tests multiplex-engineered NK cells in rhesus macaques to target HIV reservoirs by enhancing homing to B cell follicles.

bioRxiv · Jun 11, 2026 · PreprintBioengineering

Modeling CISH-KO TIL therapy: T-cell persistence and endogenous competition determine response in gastrointestinal cancer

Xuanming Zhang, Sarah Anderson, Kamran Kaveh, Matthew J Johnson, David J. Odde, Beau R. Webber, Branden S. Moriarity, Emil Lou, Kevin Leder, Jasmine Foo

This study models CISH-KO TIL therapy in gastrointestinal cancer, finding that T-cell persistence and endogenous competition are key determinants of treatment response.

bioRxiv · Jun 11, 2026 · PreprintCancer Biology